"Innovative drug concept stocks are active again, and Xinnowei's closing price surged by 20%."

The concept of innovative pharmaceutical stocks has been repeatedly active, with Xinnowei closing up 20cm limit, Changshan Pharmaceutical rising more than 16% to hit a historical high, Maiwei Bio and Sailun Bio soaring more than 10%, and Haichuang Pharmaceutical and Shenzhou Cell following suit.